PENNSYLVANIA
|
|
No.
23-0993790
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
One
Quaker Park
901
Hector Street
Conshohocken,
Pennsylvania 19428
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(610)
832-4000
|
(Registrant’s
telephone number, including area code)
|
(Former
name or former address, if changed since last
report)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Exhibit
No.
|
|
99.1
|
Press
Release of Quaker Chemical Corporation dated May 1, 2007.
|
QUAKER
CHEMICAL CORPORATION
Registrant
|
|||
Date:
May 2, 2007
|
By:
|
/s/
Mark A. Featherstone
|
|
Mark
A. Featherstone
Vice
President and Chief
Financial Officer
|
|
|||
For
Release:
Immediate
|
NEWS
|
Contact:
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
610-832-4160
|
Quaker
Chemical Corporation
|
|||||||
Condensed
Consolidated Statement of Income
|
|||||||
(Dollars
in thousands, except per share data and share
amounts)
|
(Unaudited)
|
|||||||
Three
Months ended March 31,
|
|||||||
2007
|
2006
|
||||||
Net
sales
|
$
|
124,891
|
$
|
109,816
|
|||
Cost
of goods sold
|
86,345
|
77,331
|
|||||
Gross
margin
|
38,546
|
32,485
|
|||||
%
|
30.9
|
%
|
29.6
|
%
|
|||
Selling,
general and administrative
|
31,919
|
27,362
|
|||||
Operating
income
|
6,627
|
5,123
|
|||||
%
|
5.3
|
%
|
4.7
|
%
|
|||
Other
income, net
|
327
|
128
|
|||||
Interest
expense, net
|
(1,350
|
)
|
(965
|
)
|
|||
Income
before taxes
|
5,604
|
4,286
|
|||||
Taxes
on income
|
1,844
|
1,553
|
|||||
3,760
|
2,733
|
||||||
Equity
in net income of associated companies
|
125
|
113
|
|||||
Minority
interest in net income of subsidiaries
|
(348
|
)
|
(304
|
)
|
|||
Net
income (loss)
|
$
|
3,537
|
$
|
2,542
|
|||
%
|
2.8
|
%
|
2.3
|
%
|
|||
Per
share data:
|
|||||||
Net
income - basic
|
$
|
0.36
|
$
|
0.26
|
|||
Net
income - diluted
|
$
|
0.35
|
$
|
0.26
|
|||
Shares
Outstanding:
|
|||||||
Basic
|
9,907,683
|
9,723,432
|
|||||
Diluted
|
10,024,905
|
9,816,149
|
|||||
Quaker
Chemical Corporation
|
|||||||||||
Condensed
Consolidated Balance Sheet
|
|||||||||||
(Dollars
in thousands, except par value and share
amounts)
|
(Unaudited)
|
|||||||
March
31,
|
December
31,
|
||||||
2007
|
2006
|
||||||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
10,787
|
$
|
16,062
|
|||
Accounts
receivable, net
|
118,834
|
107,340
|
|||||
Inventories,
net
|
55,420
|
51,984
|
|||||
Prepaid
expenses and other current assets
|
12,213
|
10,855
|
|||||
Total
current assets
|
197,254
|
186,241
|
|||||
Property,
plant and equipment, net
|
61,464
|
60,927
|
|||||
Goodwill
|
40,235
|
38,740
|
|||||
Other
intangible assets, net
|
8,046
|
8,330
|
|||||
Investments
in associated companies
|
6,840
|
7,044
|
|||||
Deferred
income taxes
|
33,197
|
28,573
|
|||||
Other
assets
|
27,083
|
27,527
|
|||||
Total
assets
|
$
|
374,119
|
$
|
357,382
|
|||
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|||||||
Current
liabilities
|
|||||||
Short-term
borrowings and current portion of long-term debt
|
$
|
3,702
|
$
|
4,950
|
|||
Accounts
and other payables
|
64,404
|
56,345
|
|||||
Accrued
compensation
|
8,987
|
15,225
|
|||||
Other
current liabilities
|
15,480
|
13,659
|
|||||
Total
current liabilities
|
92,573
|
90,179
|
|||||
Long-term
debt
|
90,535
|
85,237
|
|||||
Deferred
income taxes
|
5,493
|
5,317
|
|||||
Other
non-current liabilities
|
71,139
|
61,783
|
|||||
Total
liabilities
|
259,740
|
242,516
|
|||||
Minority
interest in equity of subsidiaries
|
4,154
|
4,035
|
|||||
Shareholders'
equity
|
|||||||
Common
stock, $1 par value; authorized 30,000,000 shares;
issued
10,083,434 shares
|
10,083
|
9,926
|
|||||
Capital
in excess of par value
|
7,380
|
5,466
|
|||||
Retained
earnings
|
110,365
|
114,498
|
|||||
Accumulated
other comprehensive loss
|
(17,603
|
)
|
(19,059
|
)
|
|||
Total
shareholders' equity
|
110,225
|
110,831
|
|||||
Total
liabilities and shareholders' equity
|
$
|
374,119
|
$
|
357,382
|
|||
Quaker
Chemical Corporation
|
||||||||||||
Condensed
Consolidated Statement of Cash Flows
|
||||||||||||
For
the Three Months ended March 31,
|
||||||||||||
(Dollars
in thousands)
|
(Unaudited)
|
|||||||
2007
|
2006
|
||||||
Cash
flows from operating activities
|
|||||||
Net
income
|
$
|
3,537
|
2,542
|
||||
Adjustments
to reconcile net income to net cash used in operating activities:
|
|||||||
Depreciation
|
2,719
|
2,495
|
|||||
Amortization
|
339
|
351
|
|||||
Equity
in net income of associated companies, net of dividends
|
44
|
92
|
|||||
Minority
interest in earnings of subsidiaries
|
348
|
304
|
|||||
Deferred
income tax
|
361
|
(361
|
)
|
||||
Deferred
compensation and other, net
|
267
|
(184
|
)
|
||||
Stock-based
compensation
|
262
|
171
|
|||||
(Gain)
Loss on disposal of property, plant and equipment
|
5
|
-
|
|||||
Insurance
settlement realized
|
(265
|
)
|
(72
|
)
|
|||
Pension
and other postretirement benefits
|
(869
|
)
|
(1,865
|
)
|
|||
Increase
(decrease) in cash from changes in current assets and current liabilities,
net of acquisitions:
|
|||||||
Accounts
receivable
|
(10,633
|
)
|
(6,425
|
)
|
|||
Inventories
|
(3,019
|
)
|
(3,696
|
)
|
|||
Prepaid
expenses and other current assets
|
(873
|
)
|
(2,330
|
)
|
|||
Accounts
payable and accrued liabilities
|
2,749
|
245
|
|||||
Change
in restructuring liabilities
|
—
|
(2,912
|
)
|
||||
Net
cash used in operating activities
|
(5,028
|
)
|
(11,645
|
)
|
|||
Cash
flows from investing activities
|
|||||||
Capital
expenditures
|
(2,721
|
)
|
(1,655
|
)
|
|||
Payments
related to acquisitions
|
(1,000
|
)
|
(1,000
|
)
|
|||
Insurance
settlement received and interest earned
|
143
|
75
|
|||||
Change
in restricted cash, net
|
122
|
(3
|
)
|
||||
Net
cash used in investing activities
|
(3,456
|
)
|
(2,583
|
)
|
|||
Cash
flows from financing activities
|
|||||||
Net
(decrease) increase in short-term borrowings
|
(1,262
|
)
|
(2,504
|
)
|
|||
Proceeds
from long-term debt
|
5,277
|
12,340
|
|||||
Repayments
of long-term debt
|
(225
|
)
|
(233
|
)
|
|||
Dividends
paid
|
(2,137
|
)
|
(2,090
|
)
|
|||
Stock
options exercised, other
|
1,809
|
101
|
|||||
Distributions
to minority shareholders
|
(270
|
)
|
(350
|
)
|
|||
Net
cash provided by financing activities
|
3,192
|
7,264
|
|||||
Effect
of exchange rate changes on cash
|
17
|
448
|
|||||
Net
decrease in cash and cash equivalents
|
(5,275
|
)
|
(6,516
|
)
|
|||
Cash
and cash equivalents at the beginning of the period
|
16,062
|
16,121
|
|||||
Cash
and cash equivalents at the end of the period
|
$
|
10,787
|
$
|
9,605
|
|||